These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9551530)

  • 21. Genetic variation in the human hepatic cytochrome P-450 system.
    Kalow W
    Eur J Clin Pharmacol; 1987; 31(6):633-41. PubMed ID: 3549324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunological characterization of constitutive isozymes of cytochrome P-450 from rainbow trout. Evidence for homology with phenobarbital-induced rat P-450s.
    Miranda CL; Wang JL; Henderson MC; Buhler DR
    Biochim Biophys Acta; 1990 Feb; 1037(2):155-60. PubMed ID: 2306470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regiochemistry of cytochrome P450 isozymes.
    Oguri K; Yamada H; Yoshimura H
    Annu Rev Pharmacol Toxicol; 1994; 34():251-79. PubMed ID: 8042852
    [No Abstract]   [Full Text] [Related]  

  • 24. Regulation of phenobarbital-inducible cytochrome P-450s in rat and mouse liver following dexamethasone administration and hypophysectomy.
    Meehan RR; Forrester LM; Stevenson K; Hastie ND; Buchmann A; Kunz HW; Wolf CR
    Biochem J; 1988 Sep; 254(3):789-97. PubMed ID: 3058117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolism of (R)-(+)-pulegone and (R)-(+)-menthofuran by human liver cytochrome P-450s: evidence for formation of a furan epoxide.
    Khojasteh-Bakht SC; Chen W; Koenigs LL; Peter RM; Nelson SD
    Drug Metab Dispos; 1999 May; 27(5):574-80. PubMed ID: 10220485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disruption of hepatic heme biosynthesis after interaction of xenobiotics with cytochrome P-450.
    Marks GS; McCluskey SA; Mackie JE; Riddick DS; James CA
    FASEB J; 1988 Sep; 2(12):2774-83. PubMed ID: 3044903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pharmacogenetics and antiepileptic drug metabolism: implication of genetic variants in cytochromes P450].
    Saldaña-Cruz AM; Sánchez-Corona J; Márquez de Santiago DA; García-Zapién AG; Flores-Martínez SE
    Rev Neurol; 2013 May; 56(9):471-9. PubMed ID: 23629749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenotyping of cytochromes P-450 in human tissues with monoclonal antibodies.
    Fujino T; Park SS; West D; Gelboin HV
    Proc Natl Acad Sci U S A; 1982 Jun; 79(12):3682-6. PubMed ID: 6980417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Purification and characterization of liver microsomal cytochromes p-450: electrophoretic, spectral, catalytic, and immunochemical properties and inducibility of eight isozymes isolated from rats treated with phenobarbital or beta-naphthoflavone.
    Guengerich FP; Dannan GA; Wright ST; Martin MV; Kaminsky LS
    Biochemistry; 1982 Nov; 21(23):6019-30. PubMed ID: 6758842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Heterologous expression of functionally active human cytochrome P-450s. Cytochrome P-450IIIA4 catalyzes the biotransformation of the anabolic steroid hormone methandrostenolone].
    Krynetskiĭ EIu; Kovaleva IE; Luzikov VN
    Biokhimiia; 1994 Feb; 59(2):282-7. PubMed ID: 8155788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene conversion in a cytochrome P-450 gene family.
    Atchison M; Adesnik M
    Proc Natl Acad Sci U S A; 1986 Apr; 83(8):2300-4. PubMed ID: 3458196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Study of P450 function using gene knockout and transgenic mice.
    Gonzalez FJ; Kimura S
    Arch Biochem Biophys; 2003 Jan; 409(1):153-8. PubMed ID: 12464254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure and regulation of P-450s in the rat P450IIA gene subfamily.
    Gonzalez FJ; Matsunaga T; Nagata K
    Drug Metab Rev; 1989; 20(2-4):827-37. PubMed ID: 2806080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human drug metabolising cytochrome P450 enzymes: properties and polymorphisms.
    Ingelman-Sundberg M
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Jan; 369(1):89-104. PubMed ID: 14574440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Purification and characterization of six cytochrome P-450 isozymes from human liver microsomes.
    Wang PP; Beaune P; Kaminsky LS; Dannan GA; Kadlubar FF; Larrey D; Guengerich FP
    Biochemistry; 1983 Nov; 22(23):5375-83. PubMed ID: 6418201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytochrome p-450-mediated differential oxidative modification of proteins: albumin, apolipoprotein E, and CYP2E1 as targets.
    Choi DW; Leininger-Muller B; Wellman M; Kim YH; Siest G
    J Toxicol Environ Health A; 2004 Dec; 67(23-24):2061-71. PubMed ID: 15513903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Eight inhibitory monoclonal antibodies define the role of individual P-450s in human liver microsomal diazepam, 7-ethoxycoumarin, and imipramine metabolism.
    Yang TJ; Krausz KW; Sai Y; Gonzalez FJ; Gelboin HV
    Drug Metab Dispos; 1999 Jan; 27(1):102-9. PubMed ID: 9884317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Purification, characterization and regulation of five rat hepatic microsomal cytochrome P-450 isozymes.
    Ryan DE; Thomas PE; Reik LM; Levin W
    Xenobiotica; 1982 Nov; 12(11):727-44. PubMed ID: 7168193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [P450: new functions and application to practical sciences].
    Imai Y; Kamataki T
    Tanpakushitsu Kakusan Koso; 1998 Mar; 43(3):203-15. PubMed ID: 9528352
    [No Abstract]   [Full Text] [Related]  

  • 40. Whole spectrum of cytochrome P450 genes and molecular responses to water-accommodated fractions exposure in the marine medaka.
    Rhee JS; Kim BM; Choi BS; Choi IY; Wu RS; Nelson DR; Lee JS
    Environ Sci Technol; 2013 May; 47(9):4804-12. PubMed ID: 23573833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.